Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cocrystal Pharma Inc
(NQ:
COCP
)
1.820
+0.110 (+6.43%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cocrystal Pharma Inc
< Previous
1
2
3
Next >
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
August 15, 2024
Via
ACCESSWIRE
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024
August 14, 2024
COCP stock results show that Cocrystal Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024
May 13, 2024
COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 10, 2024
Via
Benzinga
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023
March 28, 2024
COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: Cocrystal Pharma Q4 Earnings
March 28, 2024
Via
Benzinga
Recap: Cocrystal Pharma Q3 Earnings
November 13, 2023
Via
Benzinga
Analyst Ratings for Cocrystal Pharma
August 15, 2023
Via
Benzinga
Why Cocrystal Pharma Shares Are Trading Higher Today
April 10, 2023
Cocrystal Pharma (NASDAQ: COCP) shares are trading higher after the company completed a $4 million private placement.
Via
Benzinga
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
March 05, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 15, 2023
Via
Benzinga
$2M Bet On Cocrystal Pharma? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
April 10, 2023
The Dow Jones closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via
Benzinga
Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) jumped 149.6% to $0.2623 in pre-market trading after dropping over 13% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 07, 2023
Via
Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 25, 2023
Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a...
Via
Benzinga
Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast
January 23, 2023
Phoenix, Arizona--(Newsfile Corp. - January 23, 2023) - The Stock Day Podcast welcomed Cocrystal Pharma, Inc. (NASDAQ: COCP) ("Cocrystal," "Cocrystal...
Via
Newsfile
Exposures
COVID-19
Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022
December 01, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
Cocrystal Pharma Posts Favorable Safety Data From Oral Antiviral Against Influenza A
November 17, 2022
Via
Benzinga
Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A
November 17, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
November 14, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Cocrystal Pharma to Participate in Two Investor Conferences in November
November 02, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Via
Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
November 02, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Via
Benzinga
Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza
November 01, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
October 26, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Cocrystal Pharma to Present at the LD Micro Main Event XV
October 19, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Cocrystal Pharma to Present CC-42344 Phase 1 Influenza A Data at the World Antiviral Congress 2022
October 13, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.